Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment, 53279 [E9-24934]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 199 / Friday, October 16, 2009 / Notices
guidance to the Director, CDC, and Director,
CCID, in the following areas: program goals
and objectives; strategies; program
organization and resources for infectious
disease prevention and control; and program
priorities.
Matters To Be Discussed: Agenda items
will include:
1. Working Groups: Environmental
Microbiology, research to guide public health
practice (National Center for Preparedness,
Detection, and Control of Infectious Diseases;
National Center for Immunization and
Respiratory Diseases (NCIRD); and National
Center for Zoonotic, Vector-Borne, and
Enteric Diseases (NCZVED) Morning
Session); Strategic Plan (National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention); Review of Funding provided
through the American Recovery and
Reinvestment Act of 2009 (ARRA) for
immunization programs funded under
Section 317 of the Public Health Service Act
(NCIRD Afternoon Session); Strategic
Framework and Program Reviews and
Strategies (NCZVED Afternoon Session).
2. Full Board:
H1N1 discussion; announcements and
introductions; and follow-up on actions
recommended by the board.
Agenda items are subject to change as
priorities dictate.
Written comments are welcome and should
be received by the contact person listed
below prior to the opening of the meeting.
Contact Person For More Information:
Harriette Lynch, Office of the Director, CCID,
CDC, Mailstop E–77, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, e-mail:
hlynch@cdc.gov, Telephone (404) 498–2726.
The Director, Management Analysis and
Services office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 8, 2009.
Andre Tyler,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–24937 Filed 10–15–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Health Resources and Services
Administration; CDC/HRSA Advisory
Committee on HIV and STD Prevention
and Treatment
In accordance with section l0(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC and HRSA
announce the following meeting of the
aforementioned committee:
Times and Dates:
8 a.m.–5:30 p.m., November 2, 2009.
8 a.m.–3 p.m., November 3, 2009.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue (One Bethesda Metro
Center), Bethesda, Maryland 20814,
Telephone: (301) 657–1234.
Status: Open to the public, limited only by
the space available. The meeting room will
accommodate approximately 100 people.
Purpose: This Committee is charged with
advising the Director, CDC, and the
Administrator, HRSA, regarding activities
related to prevention and control of HIV/
AIDS and other STDs, the support of health
care services to persons living with HIV/
AIDS, and education of health professionals
and the public about HIV/AIDS and other
STDs.
Matters to be Discussed: Agenda items
include issues pertaining to: (1) HIV/STD/
HCV Prevention, Treatment and Care in
Federally Qualified Health Centers; (2)
Biomedical Approaches to HIV Prevention—
Pre-Exposure Prophylaxis; (3) Federal
Adolescent Sexual Health Education
Initiatives; and (4) Role of Surveillance in
Informing CDC and HRSA Activities.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Coordinating Center for
Infectious Diseases, Strategic Business Unit,
CDC, 1600 Clifton Road, NE., Mailstop E–07,
Atlanta, Georgia 30333, Telephone: (404)
639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 8, 2009.
Andre Tyler,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–24934 Filed 10–15–09; 8:45 am]
BILLING CODE 4163–18–P
jlentini on DSKJ8SOYB1PROD with NOTICES
BILLING CODE 4163–18–P
VerDate Nov<24>2008
16:37 Oct 15, 2009
Jkt 220001
53279
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Request for Nominations for Voting
Members on Public Advisory Panels or
Committees
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is requesting
nominations for voting members to
serve on the Device Good
Manufacturing Practice Advisory
Committee, certain device panels of the
Medical Devices Advisory Committee,
the National Mammography Quality
Assurance Advisory Committee, and the
Technical Electronic Products Radiation
Safety Standards Committee in the
Center for Devices and Radiological
Health. Nominations will be accepted
for current vacancies and those that will
or may occur through August 31, 2010.
FDA has a special interest in ensuring
that women, minority groups, and
individuals with disabilities are
adequately represented on advisory
committees and, therefore, encourages
nominations of qualified candidates
from these groups.
DATES: Because scheduled vacancies
occur on various dates throughout each
year, no cutoff date is established for the
receipt of nominations. However, when
possible, nominations should be
received at least 6 months before the
date of scheduled vacancies for each
year, as indicated in this notice.
ADDRESSES: All nomination for
membership should be sent
electronically to CV@OC.FDA.GOV, or
by mail to Advisory Committee
Oversight & Management Staff (HF–4),
5600 Fishers Lane, rm. 14C03,
Rockville, MD 20857. Information about
becoming a member on a FDA advisory
committee can also be obtained by
visiting FDA’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm.
FOR FURTHER INFORMATION CONTACT: For
specific Committee questions, contact
the following persons listed in table 1 of
this document.
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 74, Number 199 (Friday, October 16, 2009)]
[Notices]
[Page 53279]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-24934]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Health Resources and Services Administration; CDC/HRSA Advisory
Committee on HIV and STD Prevention and Treatment
In accordance with section l0(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC and HRSA announce the following
meeting of the aforementioned committee:
Times and Dates:
8 a.m.-5:30 p.m., November 2, 2009.
8 a.m.-3 p.m., November 3, 2009.
Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue (One
Bethesda Metro Center), Bethesda, Maryland 20814, Telephone: (301)
657-1234.
Status: Open to the public, limited only by the space available.
The meeting room will accommodate approximately 100 people.
Purpose: This Committee is charged with advising the Director,
CDC, and the Administrator, HRSA, regarding activities related to
prevention and control of HIV/AIDS and other STDs, the support of
health care services to persons living with HIV/AIDS, and education
of health professionals and the public about HIV/AIDS and other
STDs.
Matters to be Discussed: Agenda items include issues pertaining
to: (1) HIV/STD/HCV Prevention, Treatment and Care in Federally
Qualified Health Centers; (2) Biomedical Approaches to HIV
Prevention--Pre-Exposure Prophylaxis; (3) Federal Adolescent Sexual
Health Education Initiatives; and (4) Role of Surveillance in
Informing CDC and HRSA Activities.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh,
Coordinating Center for Infectious Diseases, Strategic Business
Unit, CDC, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia
30333, Telephone: (404) 639-8317.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: October 8, 2009.
Andre Tyler,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E9-24934 Filed 10-15-09; 8:45 am]
BILLING CODE 4163-18-P
